Pharmacokinetics, safety, and tolerability of dispersible and immediate-release abacavir, dolutegravir, and lamivudine tablets in children with HIV (IMPAACT 2019): week 24 results of an open-label, multicentre, phase 1-2 dose-confirmation study

Journal: Lancet HIV

Volume: 

Issue: 

Year of Publication: 2023

Affiliated Institutions: 

Statistics

Citations :  2
Authors :  0

Identifiers

Doi : 10.1016/S2352-3018(23)00107-8
SSN : 

Study Population

Male,Female

Mesh Terms

Other Terms

Study Design

Study Approach

Country of Study

190

Publication Country